NORD Expands Network of Rare Disease Centers of Excellence for Enhanced Care
Expanding Care for Rare Diseases in America
The National Organization for Rare Disorders (NORD) recently announced a significant expansion to its Rare Disease Centers of Excellence (RD CoE) Network. This enhancement introduces three new institutions, further solidifying a national network aimed at supporting individuals affected by rare diseases across the United States.
The New Additions
The newly designated Rare Disease Centers of Excellence include:
1. Atrium Health Rare Disease Center in North Carolina
- Directors: Debra Regier, MD, PhD, and Christine Erdie-Lalena, MD, FAAP
2. Northwell Health/Cohen Children's Medical Center NORD Rare Diagnosis Center of Excellence in New York
- Director: Ian Krantz, MD
- Associate Director: Michelle Duffe, MS, CGC
3. UC San Diego Rady Children's Health San Diego Rare Disease Center of Excellence in California
- Director: Kristen Wigby, MD, FACMG
- Associate Director: Amit Majithia, MD
With these additions, NORD’s network now boasts 49 members across 28 states and the District of Columbia, uniting over 170 academic medical centers, research institutions, and children's hospitals. This growth emphasizes a collective mission to enhance the standard of care and research for rare diseases, which affect over 30 million Americans, encompassing more than 10,000 distinct conditions.
A Vision for Collaboration
Pamela Gavin, CEO of NORD, expressed pride in these new additions, noting that their clinical expertise and collaborative efforts will further unify the national network. The RD CoE Network aims to bridge gaps in rare disease research and treatment by connecting institutions with diverse specialties, ensuring that expertise is not siloed within single organizations.
"The challenges surrounding over 10,000 rare diseases cannot be tackled by isolated institutions," said Gavin. By fostering collaboration and knowledge sharing, the network aspires to transform the healthcare landscape for those dealing with these unique conditions.
Addressing Fragmentation in Care
Despite the growing recognition of rare diseases, the clinical approach remains fragmented, making it hard for patients to access specialists or participate in research initiatives. NORD’s network was created to overcome these obstacles by establishing robust referral pathways and providing a forum for healthcare professionals to collaborate. Through cross-network case conferences, the network has engaged more than 2,000 healthcare professionals and patients, addressing nearly 90 complicated rare disease cases, significantly benefiting the community.
Rigorous Designation Process
To become a designated NORD Rare Disease Center of Excellence, institutions must undergo a stringent evaluation process. They must meet specific benchmarks that ensure comprehensive services, including genetics, coordinated pediatric and adult care, and a commitment to rare disease research and education. This structure aims to build a solid foundation for improving rare disease care, enhancing the potential for future discoveries and treatment options.
Conclusion
As the NORD Rare Disease Centers of Excellence Network approaches its fifth anniversary, its focus on collaboration and innovation in patient care is clearer than ever. The recent additions will help to continue the momentum toward creating a comprehensive healthcare infrastructure for rare diseases, optimizing access to care, and ultimately improving the lives of millions of individuals with rare conditions. For more detailed information on the expanding network and its impact, visit NORD's official site.
Together, through partnerships and shared expertise, we can bring hope and advancements in treatment to those living with rare diseases across the country.